European clinical practice recommendations on opioids for chronic noncancer pain – Part 2: Special situations

• Published in: European journal of pain 2021-05, Vol.25 (5), p.969-985
• Main Authors: Krčevski Škvarč, Nevenka, Morlion, Bart, Vowles, Kevin E., Bannister, Kirsty, Buchsner, Eric, Casale, Roberto, Chenot, Jean‐François, Chumbley, Gillian, Drewes, Asbjørn Mohr, Dom, Geert, Jutila, Liisa, O'Brien, Tony, Pogatzki‐Zahn, Esther, Rakusa, Martin, Suarez–Serrano, Carmen, Tölle, Thomas, Häuser, Winfried
• Format: Article
• Language: English
• Subjects: Adolescent; Analgesics, Opioid - adverse effects; Child; Chronic Pain - drug therapy; Europe; Humans; North America; Opioid-Related Disorders
• ISSN: 1090-3801; 1532-2149
• DOI: 10.1002/ejp.1744

Background Opioid use for chronic non‐cancer pain (CNCP) is under debate. In the absence of pan‐European guidance on this issue, a position paper was commissioned by the European Pain Federation (EFIC). Methods The clinical practice recommendations were developed by eight scientific societies and one patient self‐help organization under the coordination of EFIC. A systematic literature search in MEDLINE (up until January 2020) was performed. Two categories of guidance are given: Evidence‐based recommendations (supported by evidence from systematic reviews of randomized controlled trials or of observational studies) and Good Clinical Practice (GCP) statements (supported either by indirect evidence or by case‐series, case–control studies and clinical experience). The GRADE system was applied to move from evidence to recommendations. The recommendations and GCP statements were developed by a multiprofessional task force (including nursing, service users, physicians, physiotherapy and psychology) and formal multistep procedures to reach a set of consensus recommendations. The clinical practice recommendations were reviewed by five external reviewers from North America and Europe and were also posted for public comment. Results The European Clinical Practice Recommendations give guidance for combination with other medications, the management of frequent (e.g. nausea, constipation) and rare (e.g. hyperalgesia) side effects, for special clinical populations (e.g. children and adolescents, pregnancy) and for special situations (e.g. liver cirrhosis). Conclusion If a trial with opioids for chronic noncancer pain is conducted, detailed knowledge and experience are needed to adapt the opioid treatment to a special patient group and/or clinical situation and to manage side effects effectively. Significance If a trial with opioids for chronic noncancer pain is conducted, detailed knowledge and experience are needed to adapt the opioid treatment to a special patient group and/or clinical situation and to manage side effects effectively. A collaboration of medical specialties and of all health care professionals is needed for some special populations and clinical situations.